Patents by Inventor David Conlon

David Conlon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240088857
    Abstract: A system, method and storage medium for providing an emergency alert includes reading tone, using one or more processors, information and volume level information corresponding to an emergency sound generator from memory coupled to the one or more processors; and controlling, using the one or more processors, an output sound of the emergency sound generator based on the tone information and volume level information. The tone information includes data of frequency variation over a predetermined period, and the volume level information includes data of volume level variation over the predetermined period.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Applicant: WHELEN ENGINEERING COMPANY, INC.
    Inventors: Brandon CONLON, David DORNFELD, Caleb GARRETT
  • Patent number: 7563807
    Abstract: A purification method in the preparation of a substituted 8-arylquinoline, wherein the aryl group at the 8-position contains a substituent substituted-alkenyl group, utilizes a polystyrene-based sulfonylhydrazine reactive resin to remove an aldehyde impurity.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: July 21, 2009
    Assignee: Merck & Co. Inc.
    Inventors: Mirlinda Biba, Paul Compton Collins, Christopher Joseph Welch, David A. Conlon, Antoinette Drahus
  • Publication number: 20070142635
    Abstract: Processes for preparing 10-amino-3-hydroxy-4-oxo-4,6,7,8,9,10-hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds are disclosed. The preparation of carboxamide derivatives from these carboxylates is also disclosed. The carboxamides are HIV integrase inhibitors and are useful for treating HIV infection and AIDS.
    Type: Application
    Filed: December 8, 2004
    Publication date: June 21, 2007
    Inventors: David Askin, David Conlon, Yoshinori Kohmura, Jaemoon Lee, Brenda Pipik, Yong-Li Zhong
  • Publication number: 20070054941
    Abstract: A purification method in the preparation of a substituted 8-arylquinoline, wherein the aryl group at the 8-position contains a substituent substituted-alkenyl group, utilizes a polystyrene-based sulfonylhydrazine reactive resin to remove an aldehyde impurity.
    Type: Application
    Filed: September 12, 2003
    Publication date: March 8, 2007
    Inventors: Mirlinda Biba, Paul Collins, Christopher Welch, David Conlon, Antoinette Drahus
  • Publication number: 20050192346
    Abstract: The invention encompasses a novel process for making compounds of Formula I which are prodrugs of cyclooxygenase-2 selective inhibitors that convert in vivo to diaryl-2-(5H)-furanones and also liberate nitric oxide in vivo. As such, the compounds made by the present invention may be co-dosed with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions, effectively reduce the risk of thrombotic cardiovascular events and potentially renal side effects and at the same time reduce the risk of GI ulceration or bleeding. The present invention describes an efficient and economical process for the preparation of 2,3-disubstituted (2Z)-4-acetoxybut-2-enoate derivatives that is useful for the production of kilogram quantities of material for preclinical and clinical use.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 1, 2005
    Inventors: Yao-Jun Shi, F. Conrad Engelhardt, Cameron John Cowden, David Conlon, Brenda Pipik
  • Patent number: 6835837
    Abstract: A substituted 8-aryl quinoline and its benzenesulfonic acid salt is synthesized.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: December 28, 2004
    Assignee: Merck & Co. Inc.
    Inventors: Richard Desmond, David A. Conlon, Antoinette Drahus, Guo-Jie Ho, Brenda Pipik, Carl Leblond, Anant Vailaya
  • Patent number: 6740666
    Abstract: Novel sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, 2-naphthalenesulfonic acid, hydrochloride acid, or benzenesulfonic acid salts of substituted 8-arylquinolines, wherein the aryl group at the 8-position contains a substituent substituted-alkenyl group, are PDE4 inhibitors.
    Type: Grant
    Filed: November 9, 2001
    Date of Patent: May 25, 2004
    Assignees: Merck & Co., Inc., Merck Frosst Canada & Co.
    Inventors: Dwight Macdonald, Helene Perrier, Roch Thibert, Guo-Jie Ho, Anant Vailaya, David Conlon, Elizabeth Kwong, Sophie-Dorothee Clas
  • Publication number: 20040044213
    Abstract: A substituted 8-aryl quinoline and its benzenesulfonic acid salt is synthesized.
    Type: Application
    Filed: May 15, 2003
    Publication date: March 4, 2004
    Inventors: Richard Desmond, David A. Conlon, Antoinette Drahus, Guo-Jie Ho, Brenda Pipik, Carl Leblond, Anant Vailaya
  • Publication number: 20030097001
    Abstract: A substituted 8-aryl quinoline and its benzenesulfonic acid salt is synthesized.
    Type: Application
    Filed: December 18, 2001
    Publication date: May 22, 2003
    Inventors: Richard Desmond, David A. Conlon, Antoinette Drahus, Guo-Jie Ho, Brenda Pipik, Carl Leblond, Anant Vailaya
  • Publication number: 20020143032
    Abstract: Novel sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, 2-naphthalenesulfonic acid, hydrochloride acid, or benzenesulfonic acid salts of substituted 8-arylquinolines, wherein the aryl group at the 8-position contains a substituent substituted-alkenyl group, are PDE4 inhibitors.
    Type: Application
    Filed: November 9, 2001
    Publication date: October 3, 2002
    Inventors: Dwight Macdonald, Helene Perrier, Roch Thibert, Guo-Jie Ho, Anant Vailaya, David Conlon, Elizabeth Kwong, Sophie-Dorothee Clas
  • Patent number: 5523477
    Abstract: The present invention provides a novel process for the preparation of 1,1-cyclopropanedimethanol cyclic sulfite which comprises: (a) contacting 1,1-cyclopropanedimethanol with dialkylsulfite in the presence of a base; and (b) removing from the reaction mixture the alcohol reaction by-product. This process is incorporated in the additional novel processes for preparing 1-(hydroxymethyl)cyclopropaneacetonitrile and 1-(thiomethyl)cyclopropaneacetic acid.
    Type: Grant
    Filed: January 23, 1995
    Date of Patent: June 4, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Steven King, Brenda Pipik, David A. Conlon
  • Patent number: 5116204
    Abstract: A display device comprises an elongate member which is formed of two identical moldings and rotatably mounted on two nylon bearings, each of which is secured to a post. One molding is oriented in a first direction and a second molding is oriented in a second opposite direction and the two moldings are engageable in the longitudinal direction. A male rim section of one molding engages in a female rim section of the second molding. Each side of the female rim section has a plurality of supporting lugs which support the male rim section of the other molding when engaged.
    Type: Grant
    Filed: September 4, 1990
    Date of Patent: May 26, 1992
    Inventors: Peter A. Power, Adrian P. Power, Julian M. Power, David Conlon
  • Patent number: 4864054
    Abstract: A method is provided for making cationically polymerizable aromatic polypropenylethers and to the aromatic polypropenylethers made thereby. Aromatic polyalkylene glycol prepared from the corresponding polyphenol is reacted with an allylhalide to produce aromatic polyallylether which is thereafter isoemrized to the corresponding cationically polymerizable aromatic polypropenylether.
    Type: Grant
    Filed: May 2, 1983
    Date of Patent: September 5, 1989
    Assignee: General Electric Company
    Inventors: James V. Crivello, David A. Conlon